Clinical Trial Update: 1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 clinical trial evaluating Erwinaze for Acute Myeloid Leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Erwinaze (Asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: Ashkan Emadi | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED